Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Abnormal MDMX degradation in tumor cells due to ARF deficiency.
Li X, Gilkes D, Li B, Cheng Q, Pernazza D, Lawrence H, Lawrence N, Chen J.
Oncogene. 2011 Nov 28. doi: 10.1038/onc.2011.534. [Epub ahead of print]
Related citations
A critical role for noncoding 5S rRNA in regulating Mdmx stability.
Li M, Gu W.
Mol Cell. 2011 Sep 16;43(6):1023-32.
Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
Nie J, Xie P, Liu L, Xing G, Chang Z, Yin Y, Tian C, He F, Zhang L.
J Biol Chem. 2010 Jul 23;285(30):22818-30. Epub 2010 May 18.
Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.
Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Szekely L, Bercovich B, Ciechanover A, Klein G.
Int J Cancer. 2011 Feb 15;128(4):817-25. doi: 10.1002/ijc.25414.
MdmX is a substrate for the deubiquitinating enzyme USP2a.
Allende-Vega N, Sparks A, Lane DP, Saville MK.
Oncogene. 2010 Jan 21;29(3):432-41. Epub 2009 Oct 19.
Ribosomal protein S7 is both a regulator and a substrate of MDM2.
Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X, Prives C.
Mol Cell. 2009 Aug 14;35(3):316-26.
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
Okamoto K, Taya Y, Nakagama H.
FEBS Lett. 2009 Sep 3;583(17):2710-4. Epub 2009 Jul 18.
Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2.
Ohtsubo C, Shiokawa D, Kodama M, Gaiddon C, Nakagama H, Jochemsen AG, Taya Y, Okamoto K.
Cancer Sci. 2009 Jul;100(7):1291-9. Epub 2009 Apr 27.
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
Linke K, Mace PD, Smith CA, Vaux DL, Silke J, Day CL.
Cell Death Differ. 2008 May;15(5):841-8. Epub 2008 Jan 25.
Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
Singh RK, Iyappan S, Scheffner M.
J Biol Chem. 2007 Apr 13;282(15):10901-7. Epub 2007 Feb 14.
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
Okamoto K, Kashima K, Pereg Y, Ishida M, Yamazaki S, Nota A, Teunisse A, Migliorini D, Kitabayashi I, Marine JC, Prives C, Shiloh Y, Jochemsen AG, Taya Y.
Mol Cell Biol. 2005 Nov;25(21):9608-20.
MDM2 promotes ubiquitination and degradation of MDMX.
Pan Y, Chen J.
Mol Cell Biol. 2003 Aug;23(15):5113-21.
MdmX inhibits Smad transactivation.
Kadakia M, Brown TL, McGorry MM, Berberich SJ.
Oncogene. 2002 Dec 12;21(57):8776-85.
MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination.
Badciong JC, Haas AL.
J Biol Chem. 2002 Dec 20;277(51):49668-75. Epub 2002 Oct 21.
MDM2 interacts with MDMX through their RING finger domains.
Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M.
FEBS Lett. 1999 Mar 19;447(1):5-9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on